Free Trial

ExodusPoint Capital Management LP Trims Stock Position in Azenta, Inc. (NASDAQ:AZTA)

Azenta logo with Medical background
Remove Ads

ExodusPoint Capital Management LP lowered its position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 39.5% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 66,649 shares of the company's stock after selling 43,526 shares during the period. ExodusPoint Capital Management LP owned about 0.15% of Azenta worth $3,332,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in AZTA. Picton Mahoney Asset Management increased its stake in shares of Azenta by 305.7% in the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock valued at $35,000 after buying an additional 532 shares during the period. Headlands Technologies LLC acquired a new position in shares of Azenta during the fourth quarter valued at about $40,000. KBC Group NV boosted its stake in Azenta by 48.5% during the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after purchasing an additional 698 shares during the last quarter. Assenagon Asset Management S.A. purchased a new position in shares of Azenta during the fourth quarter valued at approximately $200,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in shares of Azenta by 14.9% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,446 shares of the company's stock worth $225,000 after acquiring an additional 576 shares in the last quarter. Institutional investors and hedge funds own 99.08% of the company's stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on AZTA. Evercore ISI upped their target price on Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a report on Thursday, February 6th. Needham & Company LLC increased their price target on Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a research note on Thursday, February 6th. Stephens reiterated an "overweight" rating and issued a $60.00 target price on shares of Azenta in a research note on Thursday, January 2nd. Finally, TD Cowen upgraded Azenta to a "hold" rating in a research note on Thursday, February 27th.

Remove Ads

Read Our Latest Report on AZTA

Azenta Trading Up 0.7 %

Shares of Azenta stock traded up $0.18 on Friday, hitting $26.71. 1,111,613 shares of the company traded hands, compared to its average volume of 630,464. The firm's 50-day simple moving average is $39.42 and its 200 day simple moving average is $44.75. Azenta, Inc. has a 12-month low of $25.36 and a 12-month high of $63.58. The company has a market cap of $1.22 billion, a P/E ratio of -8.96 and a beta of 1.66.

Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. Analysts predict that Azenta, Inc. will post 0.53 earnings per share for the current year.

About Azenta

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Featured Articles

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Should You Invest $1,000 in Azenta Right Now?

Before you consider Azenta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.

While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads